MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Conjugal Parkinsonism

    CK. Tan (Singapore, Singapore)

    Objective: To report a case of multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) in a couple. Background: Conjugal parkinsonism denotes an entity where…
  • 2025 International Congress

    A Randomized, Double-blind Phase 3 Trial of Amlenetug Versus Placebo in Patients with MSA: The MASCOT Trial

    L. Kjærsgaard, M. Nørbæk Jørgensen, S. Zanigni, J. Wiedemann, J. Luthman (Valby, Denmark)

    Objective: Describe the protocol for a randomized, double-blind phase 3 trial evaluating the efficacy and safety of amlenetug versus placebo in slowing clinical progression in…
  • 2025 International Congress

    Safety, Tolerability and Pharmacokinetics of a Novel Oral OGA Inhibitor (FNP-223) First-in-Human Phase 1 Study

    R. Pokorny, J M. Ryan, K. Abd-Elaziz, C. Varona, M. Schneider, C. Wiessner, J F. Stallaert, B. Permanne, A. Quattropani, D. Beher (Lausanne, Switzerland)

    Objective: To evaluate the safety, tolerability, and pharmacokinetics of FNP-223 (formerly ASN90) in healthy volunteers (HV). Background: Proteinopathies remain largely untreatable and novel therapies are…
  • 2025 International Congress

    Exploring Cardiac Autonomic Dysfunction in Synucleinopathies with Parkinsonism Across Awake-Sleep Stages

    N. Limotai, T. Somboon, S. Rujirussawarawong, T. Tumnark, N. Suanprasert, N. Unwanatham, C. Limotai (Bangkok, Thailand)

    Objective: To explore the differences in heart rate variability (HRV) across awake-sleep stages between patients with synucleinopathies and elderly controls without parkinsonism Background: A complex…
  • 2025 International Congress

    Novel CUX2 Mutation Identified in Patient with Clinical Paroxysmal Nonkinesigenic Dyskinesia

    C. Cheung, G. Osaki Mark, K. Mackenzie (Elk Grove, USA)

    Objective: In this case, we present a novel mutation in the regulatory region for CUX-2 that is associated with clinical PNKD. Background: Paroxysmal nonkinesigenic dyskinesias…
  • 2025 International Congress

    Stroke, Chronic Ataxia and Tremor in a Pediatric Patient with c.2137C>A Genetic Variant in CACNA1A

    A. Vargas Nino, H. Alfaris, C. Gorodetsky (Toronto, Canada)

    Objective: To describe a pediatric case of chronic non-progressive ataxia, nystagmus, kinetic tremor, refractory epilepsy, and arterial ischemic stroke (AIS) associated with a CACNA1A c.2137C>A…
  • 2025 International Congress

    Balance assessment and effect of virtual reality in Hereditary Spastic Paraplegia

    M. Severiano, G. Dos Santos, C. de Araújo, F. Gonçalves, B. Zeigelboim, H. Teive (Curitiba, Brazil)

    Objective: This study aims to investigate the balance and benefits of Vestibular Rehabilitation (VR) with virtual reality (VRi) in individuals with HSP Background: The HSP…
  • 2025 International Congress

    Retrospective Analysis of our Supportive Care Clinic and Lifestyle Improvement Fitness Program

    N. Hellmers, A. Weiss, B. Katz, S. Fine, A. Aminpour, A. Yoo, H. Ooi, H. Sarva (New York, USA)

    Objective: The Supportive Care Clinic and Lifestyle Improvement Fitness (LIFT) program provides multidisciplinary care and online educational resources for our parkinsonian patients. Demographics of patients…
  • 2025 International Congress

    GNAI1-Associated Childhood-Onset Hyperkinetic Movement Disorder: A Case Report

    T. Larsh, A. Espay, D. Gilbert, S. Wu (Cincinnati, USA)

    Objective: To describe the clinical presentation, diagnostic evaluation, and genetic findings in a 7-year-old male with a hyperkinetic movement disorder associated with a novel GNAI1…
  • 2025 International Congress

    Preliminary Results From an Italian Multicentric Study on Inherited Synaptopathies Characterized by Movement Disorders and Epilepsy

    L. Pollini, S. Galosi, F. Nardecchia, M. Mastrangelo, M. Bologna (Rome, Italy)

    Objective: To present the preliminary results of an Italian multicentric study on inherited synaptopathies Background: Inherited synaptopathies are rare genetic disorders characterized by complex and…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley